NMTC NeuroOne Medical Technologies Corporation
USHealthcareAs of 2026-07-08 16:00
Why NMTC matters now
NeuroOne Medical Technologies Corporation (NMTC) is a US stock in Healthcare. The latest InvestLog snapshot shows $2.99 with -0.99% on the session and $26.0M in market capitalization; recent performance reads 1-month -19.95% and YTD -27.69%.
The latest financial table shown here is Q2 2026, with revenue of $2.4M, net income of $-2.1M, and EPS of $-0.25. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -26.4%.
The latest indexable market news headline is "NeuroOne Medical Technologies Corporation (NMTC) Q2 2026 Earnings Call Transcript" from Seeking Alpha.
Additional event context on this page matters because analyst consensus is Buy with a median target of $3.00; recent insider activity includes Andrle Edward filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
5.17
P/S
2.95
EV/EBITDA
-4.08
DCF Value
$-299.33
FCF Yield
-26.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
54.5%
Operating Margin
-72.7%
Net Margin
-68.3%
ROE
-98.3%
ROA
-84.5%
ROIC
-112.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q2 2026 | $2.4M | $-2.1M | $-0.25 |
| Q1 2026 | $2.9M | $-1.4M | $-0.17 |
| Q4 2025 | $2.7M | $-1.6M | $-0.26 |
| FY 2025 | $12.1M | $-3.6M | $-0.54 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$3.00
Target (Median)
$3.00
Target Range
$3.00 - $3.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Devices
Country
US
Exchange
—
Beta
0.51
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems. These systems are crafted for diverse neurophysiological applications, such as the continuous recording of electroencephalograms (cEEG) and stereoelectroencephalograms (sEEG), as well as therapeutic interventions including spinal cord stimulation, brain stimulation, and ablation procedures. The technology aims to assist individuals afflicted by conditions like epilepsy, Parkinson's disease, dystonia, essential tremors, persistent pain arising from unsuccessful back surgeries, and a variety of other neurological disorders. Furthermore, the company has forged a crucial partnership with RBC Medical Innovations to engineer a radio frequency ablation generator. This generator is designed to integrate seamlessly with NeuroOne's unique dual-function electrode, allowing for both the precise monitoring of brain electrical activity and the targeted ablation of brain tissue using a singular instrument. The corporate headquarters are situated in Eden Prairie, Minnesota.